Skip to main content
Clinical Trials/NCT00205062
NCT00205062
Terminated
Phase 4

Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease

University of Wisconsin, Madison1 site in 1 countryOctober 2004

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Inflammatory Bowel Diseases
Sponsor
University of Wisconsin, Madison
Locations
1
Primary Endpoint
Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.

Registry
clinicaltrials.gov
Start Date
October 2004
End Date
August 2008
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion Criteria

  • Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT

Outcomes

Primary Outcomes

Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?

Secondary Outcomes

  • Does this technique provide additional information for practitioners on extent of disease?

Study Sites (1)

Loading locations...

Similar Trials